| Active ingredients | Dosage form | Reason | Message type | Date of the last message | |
| Erythromycin estolate | Powder for the preparation of an oral suspension | Erhte Demand | Initial notification | 10.05.2024 | |
| Amoxicillin trihydrate | Powder for the preparation of an oral suspension | Erhte Demand | Initial notification | 10.05.2024 | |
| Sodium alendronate (Ph.Eur.) | Tablet | Insufficient production capacities | ﾄChange notification | 10.05.2024 | |
| Sodium alendronate (Ph.Eur.) | Tablet | Insufficient production capacities | ﾄChange notification | 10.05.2024 | |
| Insulin glargine | Injektionslung | Problems with the other manufacturer | ﾄChange notification | 10.05.2024 | |
| ﾄChange notification | 10.05.2024 | ||||
| ﾄChange notification | 10.05.2024 | ||||
| Trihexyphenidyl hydrochloride | Tablet | Problems in production | ﾄChange notification | 10.05.2024 | |
| Trihexyphenidyl hydrochloride | Tablet | Problems in production | ﾄChange notification | 10.05.2024 | |
| Levomethadone hydrochloride | Oral drops | Other | ﾄChange notification | 10.05.2024 | |
| Clindamycin hydrochloride monohydrate | Hard capsule | Erhte Demand | ﾄChange notification | 10.05.2024 | |
| Ciprofloxacin hydrochloride (1:1) 1 H<2>O | Film-coated tablet | Erhte Demand | ﾄChange notification | 10.05.2024 | |
| Cefadroxil monohydrate | Powder for the preparation of an oral suspension | Erhte Demand | ﾄChange notification | 10.05.2024 | |
| Cefadroxil monohydrate | Powder for the preparation of an oral suspension | Erhte Demand | ﾄChange notification | 10.05.2024 | |
| Topotecan hydrochloride | Hard capsule | Other | ﾄChange notification | 10.05.2024 | |
| Clindamycin hydrochloride monohydrate | Hard capsule | Erhte Demand | ﾄChange notification | 10.05.2024 | |
| Clindamycin hydrochloride monohydrate | Hard capsule | Erhte Demand | ﾄChange notification | 10.05.2024 | |
| Clindamycin hydrochloride monohydrate | Hard capsule | Erhte Demand | ﾄChange notification | 10.05.2024 | |
| Clindamycin hydrochloride monohydrate | Hard capsule | Erhte Demand | ﾄChange notification | 10.05.2024 | |
| ﾄChange notification | 10.05.2024 | ||||
| ﾄChange notification | 10.05.2024 | ||||
| ﾄChange notification | 10.05.2024 | ||||
| Azithromycin dihydrate | Film-coated tablet | Other | ﾄChange notification | 10.05.2024 | |
| Azithromycin dihydrate | Film-coated tablet | Other | ﾄChange notification | 10.05.2024 | |
| Levetiracetam | Lung for ingestion | Problems in production | Initial notification | 08.05.2024 | |
| Levetiracetam | Film-coated tablet | Problems in production | Initial notification | 08.05.2024 | |
| Levetiracetam | Film-coated tablet | Problems in production | Initial notification | 08.05.2024 | |
| Levetiracetam | Film-coated tablet | Problems in production | Initial notification | 08.05.2024 | |
| Levetiracetam | Film-coated tablet | Problems in production | Initial notification | 08.05.2024 | |
| Levetiracetam | Film-coated tablet | Problems in production | Initial notification | 08.05.2024 | |
| Levetiracetam | Film-coated tablet | Problems in production | Initial notification | 08.05.2024 | |
| Levetiracetam | Film-coated tablet | Problems in production | Initial notification | 08.05.2024 | |
| Levetiracetam | Film-coated tablet | Problems in production | Initial notification | 08.05.2024 | |
| Levetiracetam | Film-coated tablet | Problems in production | Initial notification | 08.05.2024 | |
| Levetiracetam | Film-coated tablet | Problems in production | Initial notification | 08.05.2024 | |
| Levetiracetam | Film-coated tablet | Problems in production | Initial notification | 08.05.2024 | |
| Levetiracetam | Lung for ingestion | Problems in production | Initial notification | 08.05.2024 | |
| Lamotrigine | Tablet | Problems in production | ﾄChange notification | 08.05.2024 | |
| Lamotrigine | Tablet | Problems in production | ﾄChange notification | 08.05.2024 | |
| Lamotrigine | Tablet | Problems in production | ﾄChange notification | 08.05.2024 | |
| Lamotrigine | Tablet | Problems in production | ﾄChange notification | 08.05.2024 | |
| Lamotrigine | Tablet | Problems in production | ﾄChange notification | 08.05.2024 | |
| Lamotrigine | Tablet | Problems in production | ﾄChange notification | 08.05.2024 | |
| Lamotrigine | Tablet | Problems in production | ﾄChange notification | 08.05.2024 | |
| Lamotrigine | Tablet | Problems in production | ﾄChange notification | 08.05.2024 | |
| Lamotrigine | Tablet for the preparation of an oral suspension | Problems in production | ﾄChange notification | 08.05.2024 | |
| Sodium alendronate (Ph.Eur.) | Tablet | Problems in production | ﾄChange notification | 08.05.2024 | |
| Flecainide acetate | Tablet | Problems in production | ﾄChange notification | 08.05.2024 | |
| Flecainide acetate | Tablet | Problems in production | ﾄChange notification | 08.05.2024 | |
| Flecainide acetate | Tablet | Problems in production | ﾄChange notification | 08.05.2024 | |
| ﾄChange notification | 08.05.2024 | ||||
| ﾄChange notification | 08.05.2024 | ||||
| ﾄChange notification | 08.05.2024 | ||||
| Salbutamol sulfate | Compressed gas inhalation | Other | ﾄChange notification | 08.05.2024 | |
| Salbutamol sulfate | Compressed gas inhalation | Other | ﾄChange notification | 08.05.2024 | |
| Salbutamol sulfate | Compressed gas inhalation | Other | ﾄChange notification | 08.05.2024 | |
| ﾄChange notification | 08.05.2024 | ||||
| Remifentanil hydrochloride | Erhte Demand | Initial notification | 08.05.2024 | ||
| Remifentanil hydrochloride | Erhte Demand | Initial notification | 08.05.2024 | ||
| Remifentanil hydrochloride | Erhte Demand | Initial notification | 08.05.2024 | ||
| Paracetamol | Erhte Demand | ﾄChange notification | 08.05.2024 | ||
| Paracetamol | Erhte Demand | ﾄChange notification | 08.05.2024 | ||
| Dimenhydrinate | Injektionslung | Problems in production | ﾄChange notification | 08.05.2024 | |
| Dimenhydrinate | Injektionslung | Problems in production | ﾄChange notification | 08.05.2024 | |
| Metoprolol tartrate (Ph.Eur.) | Prolonged-release tablet | Erhte Demand | ﾄChange notification | 08.05.2024 | |
| Fesoterodine fumarate | Prolonged-release tablet | Insufficient production capacities | ﾄChange notification | 07.05.2024 | |
| ﾄChange notification | 07.05.2024 | ||||
| Doxycycline hyclate | Injektionslung | Problems in production | Initial notification | 07.05.2024 | |
| Metamizole sodium monohydrate | Injektionslung | Other | ﾄChange notification | 07.05.2024 | |
| Metamizole sodium monohydrate | Injektionslung | Other | ﾄChange notification | 07.05.2024 | |
| Metamizole sodium monohydrate | Injektionslung | Other | ﾄChange notification | 07.05.2024 | |
| Betamethasone dipropionate (Ph.Eur.); Salicyls舫re | Lung for application on the skin | Insufficient production capacities | ﾄChange notification | 07.05.2024 | |
| Betamethasone dipropionate (Ph.Eur.); Salicyls舫re | Lung for application on the skin | Insufficient production capacities | ﾄChange notification | 07.05.2024 | |
| Vindesine sulfate | Problems in production | ﾄChange notification | 07.05.2024 | ||
| Buprenorphine hydrochloride | Sublingual tablet | Problems in production | ﾄChange notification | 06.05.2024 | |
| Buprenorphine hydrochloride | Sublingual tablet | Problems in production | ﾄChange notification | 06.05.2024 | |
| ﾄChange notification | 06.05.2024 | ||||
| ﾄChange notification | 06.05.2024 | ||||
| Linezolid | Film-coated tablet | Erhte Demand | ﾄChange notification | 06.05.2024 | |
| Linezolid | Film-coated tablet | Erhte Demand | ﾄChange notification | 06.05.2024 | |
| Initial notification | 06.05.2024 | ||||
2024年5月13日